Patent outcomes of Phase II awards
| Headcount | ||||
|---|---|---|---|---|
| 0-499 | 1-9 | 10-49 | 50-249 | |
| Panel A: Average Marginal Effect of Probability of Patenting | ||||
| Win Phase II | 0.067*** | 0.073** | 0.012 | 0.023 |
| Observations | 1,683 | 572 | 642 | 156 |
| Controls | Yes | Yes | Yes | Yes |
| Weights | Yes | Yes | Yes | Yes |
| p-value | 0 | 9e-10 | 4e-9 | 2e-3 |
| Panel B: Average Marginal Effect of Probability of Patenting for Firms Without Prior Patents | ||||
| Win Phase II | 0.042 | 0.064* | 0.133** | |
| Observations | 760 | 324 | 195 | |
| Controls | Yes | Yes | Yes | |
| Weights | Yes | Yes | Yes | |
| p-value | 3e-4 | 0.012 | 0.017 | |
| Panel C: OLS Regression Estimating ln (Forward Patents) (If Any) | ||||
| Win Phase II | −0.113 | 0.500 | −0.128 | 0.212 |
| Observations | 354 | 61 | 171 | 65 |
| Controls | Yes | Yes | Yes | Yes |
| Weights | Yes | Yes | Yes | Yes |
| Adj. | 0.148 | 0.007 | 0.198 | 0.018 |
| Headcount | ||||
|---|---|---|---|---|
| 0-499 | 1-9 | 10-49 | 50-249 | |
| Win Phase | 0.067*** | 0.073** | 0.012 | 0.023 |
| Observations | 1,683 | 572 | 642 | 156 |
| Controls | Yes | Yes | Yes | Yes |
| Weights | Yes | Yes | Yes | Yes |
| p-value | 0 | 9e-10 | 4e-9 | 2e-3 |
| Win Phase | 0.042 | 0.064* | 0.133** | |
| Observations | 760 | 324 | 195 | |
| Controls | Yes | Yes | Yes | |
| Weights | Yes | Yes | Yes | |
| p-value | 3e-4 | 0.012 | 0.017 | |
| Win Phase | −0.113 | 0.500 | −0.128 | 0.212 |
| Observations | 354 | 61 | 171 | 65 |
| Controls | Yes | Yes | Yes | Yes |
| Weights | Yes | Yes | Yes | Yes |
| Adj. | 0.148 | 0.007 | 0.198 | 0.018 |
***p < 0.01; **p < 0.05; *p < 0.1. Patent outcomes are reported for the NASA SBIR proposal pool of 2002–2012. The outcome in Panels A and B is the Average Marginal Effect of the probability of patenting for the full sample (Panel A) and the firms without prior patents (Panel B). The subsample of the largest firms in Panel B is excluded for statistical reasons. Panel C reports the coefficients of an OLS regression on the number of forward patents, conditional on patenting. The treated (with Phase II award) observations are compared to untreated (not selected for Phase II award) with a Propensity Score Matching methodology. Controls include year fixed effects and fixed effects for the NASA Center receiving the proposal
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.